Literature DB >> 5091582

Treatment of bronchogenic carcinoma with mediastinal metastases.

M M Kirsh, D R Kahn, O Gago, I Lampe, J V Fayos, M Prior, W Y Moores, C Haight, H Sloan.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 5091582     DOI： 10.1016/s0003-4975(10)65088-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


× No keyword cloud information.
  8 in total

1.  The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer.

Authors:  P Goldstraw
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

2.  MEDIASTINOSCOPY: PROCEDURE OF CHOICE FOR DIAGNOSIS AND DETERMINATION OF OPERABILITY.

Authors:  Martin D. McCurdy; Peter A. Philips; Alan T. Marty; Alfonso M. Miyamoto
Journal:  Cardiovasc Dis       Date:  1974

3.  Survival in lung cancer.

Authors:  D J Rickles; R G Parker; D J Demanes
Journal:  West J Med       Date:  1978-01

Review 4.  Pre-operative mediastinal evaluation in primary bronchial carcinoma--a review of staging investigations.

Authors:  J A Elliott
Journal:  Postgrad Med J       Date:  1984-02       Impact factor: 2.401

5.  Bronchoplasty for bronchogenic carcinoma.

Authors:  H Ayabe; Y Nakamura; T Miura; T Kugimiya; Y Koga; Y Tsuji
Journal:  World J Surg       Date:  1982-07       Impact factor: 3.352

6.  The influence of the metastasis pattern of mediastinal lymph nodes on the postoperative radiotherapy's efficacy for the IIIA-pN2 non-small-cell lung cancer: a retrospective analysis of 220 patients.

Authors:  Baozhong Zhang; Lujun Zhao; Zhiyong Yuan; Qingsong Pang; Ping Wang
Journal:  Onco Targets Ther       Date:  2016-10-11       Impact factor: 4.147

7.  Skip metastasis in mediastinal lymph node is a favorable prognostic factor in N2 lung cancer patients: a meta-analysis.

Authors:  Zihuai Wang; Jiahan Cheng; Wenyu Huang; Diou Cheng; Yilin Liu; Qiang Pu; Nathan E Reticker-Flynn; Lunxu Liu
Journal:  Ann Transl Med       Date:  2021-02

8.  Surgical management of lung cancer.

Authors:  J E Dussek
Journal:  Cancer Imaging       Date:  2000-10-10       Impact factor: 3.909
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.